{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:12:14Z","timestamp":1789056734219,"version":"build-2803163510"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2014,8,18]],"date-time":"2014-08-18T00:00:00Z","timestamp":1408320000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0105217","type":"journal-article","created":{"date-parts":[[2014,8,18]],"date-time":"2014-08-18T19:33:07Z","timestamp":1408390387000},"page":"e105217","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Evaluation of Antimalarial Activity and Toxicity of a New Primaquine Prodrug"],"prefix":"10.1371","volume":"9","author":[{"given":"Marcelo Gomes","family":"Davan\u00e7o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Caroline Campos","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro Alves","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias Carvalho","family":"Padilha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel Leandro","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cleverton Roberto","family":"de Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Marcos","family":"da Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Leandro","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung Man","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoniana Ursine","family":"Krettli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosangela Gon\u00e7alves","family":"Peccinini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,8,18]]},"reference":[{"key":"ref1","article-title":"World Malaria Report","year":"2010"},{"key":"ref2","first-page":"723","article-title":"Malaria","volume":"383","author":"NJ White","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1472-8206.2009.00709.x","article-title":"Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development","volume":"23(4)","author":"K Na-Bangchang","year":"2009","journal-title":"Fundam Clin Pharmacol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.2174\/138161209789058183","article-title":"Hybrid Drugs for Malaria","volume":"15(25)","author":"JJ Walsh","year":"2009","journal-title":"Curr Pharm Des"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.femsle.2005.09.035","article-title":"Antimalarial drug synergism and antagonism: mechanistic and clinical significance","volume":"253(2)","author":"A Bell","year":"2005","journal-title":"FEMS Microbiol Lett"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ejmech.2008.08.011","article-title":"Primaquine revisited six decades after its discovery","volume":"44(3)","author":"N Vale","year":"2009","journal-title":"Eur J Med Chem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1128\/AAC.32.6.793","article-title":"Antimalarial agents: mechanisms of action","volume":"32(6)","author":"PH Schlesinger","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/QCO.0b013e328010b848","article-title":"8-Aminoquinolines: future role as antiprotozoal drugs","volume":"19(6)","author":"BL Tekwani","year":"2006","journal-title":"Curr Opin Infect Dis"},{"key":"ref9","first-page":"621","article-title":"Mitigation of the hemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of <italic>Plasmodium vivax<\/italic> by intermittent regimens of drug administration","volume":"22(6)","author":"AS Alving","year":"1960","journal-title":"Bull World Health Organ"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2125.1984.tb02369.x","article-title":"Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite","volume":"17(4)","author":"GW Mihaly","year":"1984","journal-title":"Br J Clin Pharmacol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.bmc.2011.11.059","article-title":"A carbamate-based approach to primaquine prodrugs: antimalarial activity, chemical stability and enzymatic activation","volume":"20(2)","author":"G Mata","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.ejmech.2009.01.018","article-title":"Primaquine dipeptide derivatives bearing an imidazolidin-4-one moiety at the N-terminus as potential antimalarial prodrugs","volume":"44(6)","author":"N Vale","year":"2009","journal-title":"Eur J Med Chem"},{"key":"ref13","first-page":"449","article-title":"Development of new derivatives of primaquine by association with lysosomotropic carriers","volume":"59(3)","author":"AU Trouet","year":"1981","journal-title":"Bull World Health Organ"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1021\/jm00399a032","article-title":"Peptide derivatives of primaquine as potential antimalarial agents","volume":"31(4)","author":"A Philip","year":"1988","journal-title":"J Med Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1023\/A:1018922425551","article-title":"Dipeptide derivatives of primaquine as transmission-blocking antimalarials: effect of aliphatic side-chain acylation on the gametocytocidal activity and on the formation of carboxyprimaquine in rat liver homogenates","volume":"16(6)","author":"MJ Portela","year":"1999","journal-title":"Pharm Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/pr.112.005660","article-title":"Strategies to address low drug solubility in discovery and development","volume":"65(1)","author":"HD Williams","year":"2013","journal-title":"Pharmacol Rev"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/bdd.1807","article-title":"<italic>In vitro<\/italic> and <italic>in vivo<\/italic> evaluation of a primaquine prodrug without red blood cell membrane destabilization property","volume":"33(8)","author":"MG Davan\u00e7o","year":"2012","journal-title":"Biopharm Drug Dispos"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/424663","article-title":"Primaquine therapy for malaria","volume":"39(9)","author":"JK Baird","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1021\/js970006v","article-title":"Synthesis and in vitro evaluation of potential antichagasic dipeptide prodrugs of primaquine","volume":"86(10)","author":"MC Chung","year":"1997","journal-title":"J Pharm Sci"},{"key":"ref20","article-title":"OECD Guideline for the Testing of Chemicals. Partition Coefficient (n-octanol\/water), High Performance Liquid Chromatography (HPLC) Method","year":"1989","journal-title":"Adopted by the Council on 3th March (1989) Ref 177"},{"key":"ref21","first-page":"247","article-title":"A method for screening drugs against the liver stages of malaria using <italic>Plasmodium gallinaceum<\/italic> and <italic>Aedes mosquitoes<\/italic>","volume":"25","author":"LH Carvalho","year":"1992","journal-title":"Braz J Med Biol Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0378-8741(02)00005-3","article-title":"Antimalarial activity of medicinal plants used in traditional medicine in S. Tom\u00e9 and Pr\u00edncipe islands","volume":"81(1)","author":"M do C\u00e9u de Madureira","year":"2002","journal-title":"J. Ethnopharmacol"},{"key":"ref23","first-page":"275","article-title":"A new approach to practical acute toxicity testing. Arch","volume":"54(4)","author":"D Lorke","year":"1983","journal-title":"Toxicol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1749-6632.1968.tb11938.x","article-title":"Effects of drugs and drug metabolites on erythrocytes from normal and glucose-6-phosphate dehydrogenase-deficient individuals","volume":"151(2)","author":"IM Fraser","year":"1968","journal-title":"Ann N Y Acad Sci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bbrc.2010.10.108","article-title":"Hemolysis of human erythrocytes induced by melamine-cyanurate complex","volume":"402(4)","author":"C Wang","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1001\/jama.1962.03050180032008","article-title":"The methemoglobin reduction test for primaquine-type sensitivity of erythrocytes. A simplified procedure for detecting a specific hypersusceptibility to drug hemolysis","volume":"180","author":"GJ Brewer","year":"1962","journal-title":"JAMA"},{"key":"ref27","first-page":"268","article-title":"Avalia\u00e7\u00e3o da incid\u00eancia da defici\u00eancia de Glicose-6-Fosfato Desidrogenase (G6PD) e perfil hematol\u00f3gico em indiv\u00edduos de uma regi\u00e3o de Rond\u00f4nia. Rev. bras. hematol","volume":"26(4)","author":"TH Katsuragawa","year":"2004","journal-title":"hemoter"},{"key":"ref28","first-page":"19","article-title":"Dosagem espectrom\u00e9trica de metaemoglobina sem interferentes qu\u00edmicos ou enzim\u00e1ticos","volume":"26(1)","author":"PC Naoum","year":"2004","journal-title":"Rev Bras Hematol Hemoter"},{"key":"ref29","unstructured":"Schiff U (1866) Special techniques of microscopy. In: Scheuer PJ, Chalk B.T (Eds.), Clinical Tests Histopathology, first ed. Wolf Medical Publications Ltd., London, p. 100."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1177\/0192623310386499","article-title":"Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system","volume":"38(7)","author":"B Thoolen","year":"2010","journal-title":"Toxicol Pathol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1128\/AAC.00985-10","article-title":"Antileishmanial and antitrypanosomal activities of the 8-aminoquinoline tafenoquine","volume":"54(12)","author":"V Yardley","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/00034983.2001.11813665","article-title":"The antileishmanial properties of surface-modified, primaquine-loaded nanocapsules tested against intramacrophagic <italic>Leishmania donovani<\/italic> amastigotes in vitro","volume":"95(5)","author":"B Heurtault","year":"2001","journal-title":"Ann Trop Med Parasitol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1128\/AAC.00873-12","article-title":"Peptidomimetic and organometallic derivatives of primaquine active against <italic>Leishmania infantum<\/italic>","volume":"56(11)","author":"S Vale-Costa","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10156-009-0710-Z","article-title":"Clindamycin-primaquine versus pentamidine for the second-line treatment of pneumocystis pneumonia","volume":"15(5)","author":"T Kim","year":"2009","journal-title":"J Infect Chemother"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.2174\/092986709788682038","article-title":"Preclinical drug discovery for new anti-pneumocystis compounds","volume":"16(20)","author":"MT Cushion","year":"2009","journal-title":"Curr Med Chem"},{"key":"ref36","first-page":"247","article-title":"A method for screening drugs against the liver stages of malaria using Plasmodium gallinaceum and Aedes mosquitoes","volume":"25(3)","author":"LH Carvalho","year":"1992","journal-title":"Braz J Med Biol Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0014-4894(83)90013-9","article-title":"Plasmodium gallinaceum: avian screen for drugs with radical curative properties","volume":"55(2)","author":"RW Gwadz","year":"1983","journal-title":"Exp Parasitol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1073\/pnas.1015762108","article-title":"Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria","volume":"108(11)","author":"SA Charman","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4269\/ajtmh.1986.35.1077","article-title":"Compatibility of relapse patterns of Plasmodium cynomolgi infections in rhesus monkeys with continuous cyclical development and hypnozoite concepts of relapse","volume":"35(6)","author":"LH Schmidt","year":"1986","journal-title":"Am J Trop Med Hyg"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"931","DOI":"10.4269\/ajtmh.2012.11-0552","article-title":"Use of a rhesus Plasmodium cynomolgi model to screen for anti-hypnozoite activity of pharmaceutical substances","volume":"86(6)","author":"GA Deye","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e18162","DOI":"10.1371\/journal.pone.0018162","article-title":"Towards an in vitro model of Plasmodium hypnozoites suitable for drug discovery","volume":"6(3)","author":"L Dembele","year":"2011","journal-title":"PLoS One"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1128\/AAC.01927-13","article-title":"KAI407, a potent non-8-aminoquinoline compound that kills Plasmodium cynomolgi early dormant liver stage parasites in vitro","volume":"58(3)","author":"AM Zeeman","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-3024.1984.tb00826.x","article-title":"The effect of anti-malarial drugs on human natural killer cells <italic>in vitro<\/italic>","volume":"6(6)","author":"A Ferrante","year":"1984","journal-title":"Parasite Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bmc.2010.11.036","article-title":"Synthesis, antiprotozoal, antimicrobial, \u03b2-hematin inhibition, cytotoxicity and methemoglobin (MetHb) formation activities of bis(8-aminoquinolines)","volume":"19(1)","author":"K Kaur","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bjh.12665","article-title":"G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications","volume":"164(4)","author":"L Luzzatto","year":"2014","journal-title":"Br J Haematol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"7800","DOI":"10.1021\/jm900738c","article-title":"Imidazoquines as antimalarial and antipneumocystis agents","volume":"52(23)","author":"N Vale","year":"2009","journal-title":"J Med Chem"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/0006-2952(88)90549-7","article-title":"Effects of quinolone-containing antimalarials on the erythrocyte membrane and their significance to drug action on plasmodium falciparum","volume":"37","author":"H Ginsburg","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"ref48","first-page":"83","article-title":"A safety and efficacy trial of artesunate, sulphadoxine-pyrimethamine and primaquine in P falciparum malaria","volume":"47(3)","author":"KL Weerasinghe","year":"2002","journal-title":"Ceylon Med J"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.tox.2007.06.098","article-title":"Primaquine-induced differential gene expression analysis in mice liver using DNA microarrays","volume":"239(1\u20132)","author":"S Noel","year":"2007","journal-title":"Toxicology"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.3748\/wjg.v19.i38.6398","article-title":"New insights in bilirubin metabolism and their clinical implications","volume":"19(38)","author":"E Sticova","year":"2013","journal-title":"World J Gastroenterol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0105217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T22:39:23Z","timestamp":1588977563000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0105217"}},"subtitle":[],"editor":[{"given":"Luzia Helena","family":"Carvalho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,8,18]]},"references-count":50,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0105217","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,18]]}}}